Mikhail Blagosklonny is a renowned oncologist who has done the work for quite some time. He is an alumnus of the First Pavlov State Medical University based in St. Petersburg. Mikhail is a scientist whose concentration is in aging and cancer. Mikhail has a bias in oncology and life extension besides his general course. Mikhail served as the Oncology Professor at the Roswell Park Cancer Institute in New York City. Mikhail couples his career with the aspect of being a Medical Doctor in Internal Medicine. Mikhail undertook his Doctor of philosophy in Cardiology and Experimental medicine from the First Pavlov State University of Medicine. Mikhail served as an Associate professor attached to Medicine at the New York Medical College of in the year 2002. Mikhail later embraced a docket at the Ordway Research Institute found at Albany in New York City as a full scientist. Mikhail vacated his docket in 2009 and then took up the professorship in oncology at the Roswell Park. Mikhail’s main interests are cancer and the therapies that are targeted for cancer that helps cushion normal cells from malicious damage. Mikhail focuses on biogerontology and the drugs that are anti-aging.
Mikhail has undertaken extensive and in-depth research in the realms of cancer with a view to finding solutions to myriads of begging queries that concern cancer. Mikhail carried out a research that helped discover that Rapamycin possesses amazing healing properties that could be tapped and then injected into the human body in order to confer the edification traits. Rapamycin is majorly employed to prevent rejection of organs by the host body in the process of organ transplant. The drug is multipurpose since it has the capacity to cure some rare diseases of the lung. It was initially isolated from a bacterium in 1972 and then used as an antidote for combating fungal infection. The anti-proliferative and immunosuppressive characteristics that could be utilized in controlling some medical conditions that prevailed at that moment were discovered in the drug. Mikhail supports the use of Rapamycin to lengthen the longevity of humans.
The contributions that hail from Mikhail are so significant that they have no similitude and hence will not be overlooked. Rapamycin prevents the organ transplants from being rejected by the host body. The drug can be employed in curing the hemolytic-uremic syndrome in individuals. Rapamycin can be utilized to treat Lymphangioleiomyomatosis, coronary stent clotting, cancer, Tuberous Sclerosis Complex, facial angiofibromas, increase human longevity, Alzheimer’s disease, muscular Dystrophy and Systemic Lupus Erythematosus. Mikhail Blagosklonny is a famous philanthropist who goes an extra mile to ensure that other fellow humans are breathing easier because he lives. Mikhail has pioneered Oncology by conducting research that keeps giving insight into solving the crossword puzzle of cancer and the aging enigma. Mikhail longs to come up with the most affordable and friendly treatment that would save the patients the pain and financial constraints that they experience when seeking cancer medication in the current times. Mikhail inspires people to work and bring solutions to the unanswered queries that pop up in their minds. He tries to prove that everything is possible under the sun as long as one can endeavor to seek the solution.